Trademarkia Logo

Australia

AU$
ZELTIGNA
Cancelled: Cancelled at the request of IB

Last updated on 8 Feb 2024

Owner Info

Bioxcel Therapeutics, Inc.

555 Long Wharf Drive, 12th Floor

New Haven CT 06516, UNITED STATES OF AMERICA

Serial Number

2264502 filed on 9 Mar 2022

Correspondent

Brendan J. Hughes Cooley LLP

1299 Pennsylvania Avenue NW,,

Suite 700,

UNITED STATES OF AMERICA

ZELTIGNA

Classification Information


Class [005]
Pharmaceuticals for the treatment of central nervous system disorders; pharmaceuticals for the treatment of neurological and psychiatric disorders; ph Read More

Mark Details


Serial Number

2264502

Registered On

9 Mar 2022

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

10 Sept 2021

Mark Type

US

Legal History


Show more

Status DateAction Taken
8th Feb 2024Status change to Voided
5th Jul 2022International Registration in Australia Protected correspondence sent
4th Jul 2022IP Right Registration Published
4th Jul 2022Status change to Registered/Protected
28th Apr 2022Application Accepted correspondence sent
27th Apr 2022IP Right has been Examined
27th Apr 2022IP Right Acceptance Published
27th Apr 2022Status change to Accepted
26th Apr 2022Awaiting examination
26th Apr 2022Examination expedited